ertapenem has been researched along with Central Nervous System Disease in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chou, YC; Lee, KH; Ng, YY; Ueng, YF; Wu, CW; Yang, WC | 1 |
| Abusada, NJ; Fica, AE | 1 |
| Duquaine, S; Kitchell, E; Tannen, RC; Tate, T; Wickremasinghe, IM | 1 |
3 other study(ies) available for ertapenem and Central Nervous System Disease
| Article | Year |
|---|---|
The recommended dose of ertapenem poses a potential risk for central nervous system toxicity in haemodialysis patients - case reports and literature reviews.
Topics: Aged; Anti-Bacterial Agents; Asian People; beta-Lactams; Central Nervous System Diseases; Dose-Response Relationship, Drug; Ertapenem; Female; Humans; Male; Renal Dialysis; Renal Insufficiency | 2015 |
Seizures associated with ertapenem use in patients with CNS disorders and renal insufficiency.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactams; Central Nervous System Diseases; Ertapenem; Female; Humans; Male; Middle Aged; Renal Insufficiency; Risk Factors; Seizures | 2008 |
Central nervous system toxicity associated with ertapenem use.
Topics: Aged; Anti-Bacterial Agents; Antibiotic Prophylaxis; beta-Lactams; Central Nervous System Diseases; Delirium; Drug Monitoring; Ertapenem; Humans; Language Disorders; Male; Miosis; Osteomyelitis; Postoperative Complications; Stroke; Treatment Outcome | 2011 |